WO2005056054A3 - Procedes pour inhiber une apoptose au moyen d'inducteurs de nf-$g(k)b - Google Patents
Procedes pour inhiber une apoptose au moyen d'inducteurs de nf-$g(k)b Download PDFInfo
- Publication number
- WO2005056054A3 WO2005056054A3 PCT/US2004/040749 US2004040749W WO2005056054A3 WO 2005056054 A3 WO2005056054 A3 WO 2005056054A3 US 2004040749 W US2004040749 W US 2004040749W WO 2005056054 A3 WO2005056054 A3 WO 2005056054A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inducers
- methods
- inhibiting apoptosis
- apoptosis
- inhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/421,918 US7638485B2 (en) | 2003-12-02 | 2006-06-02 | Modulating apoptosis |
US12/617,639 US8106005B2 (en) | 2003-12-02 | 2009-11-12 | Modulating apoptosis |
US12/617,653 US8784840B2 (en) | 2003-12-02 | 2009-11-12 | Method for screening modulators of apoptosis |
US14/305,709 US9296793B2 (en) | 2003-12-02 | 2014-06-16 | Modulating apoptosis |
US15/049,953 US9585939B2 (en) | 2003-12-02 | 2016-02-22 | Protection against apoptosis from ionizing radiation |
US15/413,949 US10406206B2 (en) | 2003-12-02 | 2017-01-24 | Protection against stress-mediated damage from ionizing radiation |
US16/527,770 US11235028B2 (en) | 2003-12-02 | 2019-07-31 | Protection against stress-mediated damage from ionizing radiation |
US17/557,438 US20220105155A1 (en) | 2003-12-02 | 2021-12-21 | Protection against stress-mediated damage from ionizing radiation |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52666603P | 2003-12-02 | 2003-12-02 | |
US52646103P | 2003-12-02 | 2003-12-02 | |
US52649603P | 2003-12-02 | 2003-12-02 | |
US60/526,496 | 2003-12-02 | ||
US60/526,460 | 2003-12-02 | ||
US60/526,461 | 2003-12-02 | ||
US60/526,666 | 2003-12-02 | ||
US52646004P | 2004-12-02 | 2004-12-02 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/040750 Continuation WO2005056055A2 (fr) | 2003-12-02 | 2004-12-02 | Procedes de protection contre une irradiation au moyen d'inducteurs de nf-$g(k)b |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/040579 Continuation WO2005057218A2 (fr) | 2003-12-02 | 2004-12-02 | Methodes d'identification de modulateurs de l'apoptose issus de parasites et utilisations correspondantes |
PCT/US2004/040753 Continuation WO2005056042A2 (fr) | 2003-12-02 | 2004-12-02 | Methodes de protection contre les radiations au moyen de flagelline |
US11/421,918 Continuation US7638485B2 (en) | 2003-12-02 | 2006-06-02 | Modulating apoptosis |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005056054A2 WO2005056054A2 (fr) | 2005-06-23 |
WO2005056054A3 true WO2005056054A3 (fr) | 2006-02-09 |
Family
ID=34682349
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/040749 WO2005056054A2 (fr) | 2003-12-02 | 2004-12-02 | Procedes pour inhiber une apoptose au moyen d'inducteurs de nf-$g(k)b |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005056054A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006069198A1 (fr) | 2004-12-22 | 2006-06-29 | Cleveland Clinic Foundation | Polypeptides associes a la flagelline et utilisations de ceux-ci |
CA2732763A1 (fr) | 2008-08-01 | 2010-02-04 | Cleveland Biolabs, Inc. | Procedes pour traiter des blessures de reperfusion |
KR20140030132A (ko) | 2011-01-10 | 2014-03-11 | 클리브랜드 바이오랩스, 아이엔씨. | 암을 치료하기 위한 톨-유사 수용체 효능제의 용도 |
JP6940916B2 (ja) | 2014-07-30 | 2021-09-29 | ゲノム プロテクション,インコーポレイテッド | フラジェリン組成物および使用 |
US10183056B2 (en) | 2014-10-16 | 2019-01-22 | Cleveland Biolabs, Inc. | Methods and compositions for the treatment of radiation-related disorders |
-
2004
- 2004-12-02 WO PCT/US2004/040749 patent/WO2005056054A2/fr active Application Filing
Non-Patent Citations (10)
Title |
---|
EAVES-PYLES T D ET AL: "Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 DEC 2001, vol. 167, no. 12, 15 December 2001 (2001-12-15), pages 7009 - 7016, XP002341395, ISSN: 0022-1767 * |
EAVES-PYLES T ET AL: "Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: I kappa B alpha degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction", JOURNAL OF IMMUNOLOGY, WILLIAMS & WILKINS CO, US, vol. 166, no. 2, 15 January 2001 (2001-01-15), pages 1248 - 1260, XP002210841, ISSN: 0022-1767 * |
EGAN LAURENCE J ET AL: "IkappaB-kinasebeta-dependent NF-kappaB activation provides radioprotection to the intestinal epithelium.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 101, no. 8, 24 February 2004 (2004-02-24), pages 2452 - 2457, XP002341240, ISSN: 0027-8424 * |
GRDINA DAVID J ET AL: "Relationships between cytoprotection and mutation prevention by WR-1065.", MILITARY MEDICINE. FEB 2002, vol. 167, no. 2 Suppl, February 2002 (2002-02-01), pages 51 - 53, XP008051184, ISSN: 0026-4075 * |
HERBERT J M ET AL: "Involvement of u-PA in the anti-apoptotic activity of TGF-beta for vascular smooth muscle cells", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 413, no. 3, 1997, pages 401 - 404, XP002347628, ISSN: 0014-5793 * |
JUNG CHUL W ET AL: "Antiproliferative effect of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor", LEUKEMIA RESEARCH, vol. 23, no. 12, December 1999 (1999-12-01), pages 1105 - 1112, XP002357507, ISSN: 0145-2126 * |
KOENIG H-G ET AL: "TRANSFORMING GROWTH FACTOR BETA 1 ACTIVATES NFKB IN RAT PHEOCHROMOCYTOMA PC 12 CELLS", ABSTRACTS OF THE SOCIETY FOR NEUROSCIENCE, SOCIETY FOR NEUROSCIENCE, WASHINGTON, DC, US, vol. 27, no. 1, 2001, pages 1244, XP008053612, ISSN: 0190-5295 * |
MURLEY JEFFREY S ET AL: "Delayed cytoprotection after enhancement of Sod2 (MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active metabolite of amifostine", RADIATION RESEARCH, vol. 158, no. 1, July 2002 (2002-07-01), pages 101 - 109, XP008051326, ISSN: 0033-7587 * |
MURLEY JEFFREY S ET AL: "Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs", RADIATION RESEARCH, vol. 162, no. 5, November 2004 (2004-11-01), pages 536 - 546, XP008051185, ISSN: 0033-7587 * |
TALLANT THOMAS ET AL: "Flagellin acting via TLR5 is the major-activator of key signaling pathways leading to NF-kappaB and proinflammatory gene program activation in intestinal epithelial cells", BMC MICROBIOLOGY, vol. 4, no. 33, 23 August 2004 (2004-08-23), pages 1-24, XP002341239, ISSN: 1471-2180 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005056054A2 (fr) | 2005-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005097119A3 (fr) | Inhibiteurs de pten | |
AU2003249356A1 (en) | Safe and effective nutritional supplement formulatins and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods | |
IL173123A0 (en) | System and method for the photodynamic treatment of burns, wounds, and related skin disorders | |
AU2003300200A1 (en) | Valve treatment catheter and methods | |
AU2003300791A1 (en) | Combination therapy for the treatment of pain | |
IL175974A0 (en) | Methods of protecting against radiation using flagellin | |
WO2005037323A3 (fr) | Methode pour inhiber une signalisation de nf-kappa b et son utilisation pour traiter et pour prevenir des maladies humaines | |
AUPR839001A0 (en) | Dosage form, device and methods of treatment | |
ZA200410401B (en) | Use of thio-oxindole derivatives in treatment of skin disorders | |
EP1802350A4 (fr) | Modulation du facteur neurotrophique dérivé du cerveau (bdnf) issu de la névroglie, dans le traitement et la prévention de la douleur | |
EP1663377A4 (fr) | Dispositif medical therapeutique, son deploiement et son utilisation | |
WO2005013911A3 (fr) | Usages protecteurs et therapeutiques de tocotrienols | |
WO2003049804A3 (fr) | Traitement des troubles des voies genito-urinaires | |
AU2003274963A1 (en) | Mda-7 and free radicals in the treatment of cancer | |
WO2005056054A3 (fr) | Procedes pour inhiber une apoptose au moyen d'inducteurs de nf-$g(k)b | |
AU2002352566A1 (en) | Use of corrinoids in the treatment of skin diseases | |
AU2003221845A1 (en) | Methods of treating medication-, substance-, disease-, and other medical condition-related sexual dysfunction | |
AU2003232699A1 (en) | System and device for massage, pressure-treatment and heat-treatment of skin and parts of the body | |
EP1539100A4 (fr) | Compositions et methodes pour le traitement de troubles cutanes | |
AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain | |
AU2003244455A1 (en) | Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases | |
MXPA03000033A (es) | Procedimiento de tratamiento de enfermedades vasculares perifericas, neuropatias perifericas y neuropatias autonomicas. | |
AU2003219664A1 (en) | Methods and therapeutic compositions in the treatment of advanced cancer | |
IL164951A0 (en) | The treatment of pain with lfendropil | |
AU2003280137A1 (en) | The use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11421918 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 11421918 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |